$MLAB
MESA LABORATORIES INC /CO/

2021 Q1 Form 10-Q Financial Statement

#000143774921001796 Filed on February 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $37.96M $34.17M $34.21M
YoY Change 10.98% 7.95% 29.35%
Cost Of Revenue $13.23M $13.52M $15.57M
YoY Change -15.03% -19.78% 43.77%
Gross Profit $24.74M $20.65M $18.77M
YoY Change 31.79% 39.52% 20.21%
Gross Profit Margin 65.16% 60.44% 54.87%
Selling, General & Admin $17.68M $17.93M $15.38M
YoY Change 14.95% 14.38% 40.07%
% of Gross Profit 71.47% 86.8% 81.94%
Research & Development $2.670M $2.705M $2.310M
YoY Change 15.58% 28.2% 138.14%
% of Gross Profit 10.79% 13.1% 12.31%
Depreciation & Amortization $11.18M $4.600M $5.490M
YoY Change 103.61% 50.33% 141.85%
% of Gross Profit 45.19% 22.27% 29.25%
Operating Expenses $20.35M $20.63M $17.69M
YoY Change 15.04% 14.25% 48.03%
Operating Profit $4.386M $22.00K $1.079M
YoY Change 306.49% -100.68% -70.55%
Interest Expense -$2.110M $1.950M -$1.020M
YoY Change 106.86% 1.09%
% of Operating Profit -48.11% 8863.64% -94.53%
Other Income/Expense, Net $2.710M -$5.749M -$270.0K
YoY Change -1103.7% 215.53% -54.24%
Pretax Income $4.890M -$5.727M -$390.0K
YoY Change -1353.85% 12.8% -119.8%
Income Tax $970.0K -$1.185M $1.290M
% Of Pretax Income 19.84%
Net Earnings $3.920M -$4.542M -$1.680M
YoY Change -333.33% 0.93% -220.0%
Net Earnings / Revenue 10.33% -13.29% -4.91%
Basic Earnings Per Share $0.76 -$0.89 -$0.37
Diluted Earnings Per Share $0.74 -$0.89 -$0.37
COMMON SHARES
Basic Shares Outstanding 5.132M 5.125M 4.370M
Diluted Shares Outstanding 5.125M

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $263.9M $253.7M $81.40M
YoY Change 224.2% 242.84% 698.04%
Cash & Equivalents $263.9M $253.7M $81.38M
Short-Term Investments
Other Short-Term Assets $4.900M $9.200M $6.100M
YoY Change -19.67% 9.52% 45.24%
Inventory $11.18M $11.97M $11.18M
Prepaid Expenses
Receivables $23.79M $20.41M $21.13M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $303.7M $295.3M $122.8M
YoY Change 147.37% 144.63% 265.2%
LONG-TERM ASSETS
Property, Plant & Equipment $22.00M $22.30M $22.07M
YoY Change -0.31% -0.26% -0.72%
Goodwill $160.8M $165.8M $141.5M
YoY Change 13.64% -12.56% 113.23%
Intangibles $111.7M $120.8M $119.9M
YoY Change -6.78% 37.16% 260.85%
Long-Term Investments
YoY Change
Other Assets $2.530M $1.806M $2.480M
YoY Change 2.02% -28.13%
Total Long-Term Assets $297.7M $326.4M $286.3M
YoY Change 3.99% 7.79% 132.51%
TOTAL ASSETS
Total Short-Term Assets $303.7M $295.3M $122.8M
Total Long-Term Assets $297.7M $326.4M $286.3M
Total Assets $601.5M $621.6M $409.1M
YoY Change 47.02% 46.8% 160.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.473M $3.751M $3.408M
YoY Change 31.25% -0.77% 17.6%
Accrued Expenses $9.945M $9.165M $6.605M
YoY Change 50.57% 14.49% 64.96%
Deferred Revenue $8.777M $7.646M $6.814M
YoY Change 28.81% 20.16% 71.85%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.58M $27.75M $26.01M
YoY Change 25.28% 9.92% 9.92%
LONG-TERM LIABILITIES
Long-Term Debt $145.7M $144.3M $140.3M
YoY Change 3.85% 3.81% 580.64%
Other Long-Term Liabilities $715.0K $686.0K $1.358M
YoY Change -47.35% -50.36% 1193.33%
Total Long-Term Liabilities $715.0K $686.0K $1.358M
YoY Change -47.35% -50.36% -93.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.58M $27.75M $26.01M
Total Long-Term Liabilities $715.0K $686.0K $1.358M
Total Liabilities $195.2M $208.8M $189.1M
YoY Change 3.25% 10.33% 316.0%
SHAREHOLDERS EQUITY
Retained Earnings $72.46M $69.36M $72.36M
YoY Change 0.14% -6.66% -1.29%
Common Stock $317.7M $314.5M $158.0M
YoY Change 101.02% 102.12% 296.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $406.2M $412.8M $220.0M
YoY Change
Total Liabilities & Shareholders Equity $601.5M $621.6M $409.1M
YoY Change 47.02% 46.8% 160.97%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income $3.920M -$4.542M -$1.680M
YoY Change -333.33% 0.93% -220.0%
Depreciation, Depletion And Amortization $11.18M $4.600M $5.490M
YoY Change 103.61% 50.33% 141.85%
Cash From Operating Activities $13.52M $10.94M $8.830M
YoY Change 53.11% -0.64% -13.94%
INVESTING ACTIVITIES
Capital Expenditures -$1.040M -$240.0K -$560.0K
YoY Change 85.71% -40.0% 1020.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.040M -$240.0K -$550.0K
YoY Change 89.09% -99.87% 1000.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.050M 180.0K 400.0K
YoY Change -362.5% -150.0% -107.13%
NET CHANGE
Cash From Operating Activities 13.52M 10.94M 8.830M
Cash From Investing Activities -1.040M -240.0K -550.0K
Cash From Financing Activities -1.050M 180.0K 400.0K
Net Change In Cash 11.43M 10.88M 8.680M
YoY Change 31.68% -106.35% 88.7%
FREE CASH FLOW
Cash From Operating Activities $13.52M $10.94M $8.830M
Capital Expenditures -$1.040M -$240.0K -$560.0K
Free Cash Flow $14.56M $11.18M $9.390M
YoY Change 55.06% -2.02% -8.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5132003
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
153000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
159000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14623000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12741000 USD
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5131031
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5131031
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4387140
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4387140
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9315000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
382234000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
392412000 USD
CY2020Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5568000 USD
CY2019Q3 mlab Payments Of Debt Conversion Costs
PaymentsOfDebtConversionCosts
8338000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
230246000 USD
CY2019Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.64
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2018
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253731000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81380000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20410000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21132000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
11965000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14230000 USD
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5327000 USD
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
1914000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3842000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4136000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
295275000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
122792000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22295000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22066000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15673000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11461000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1806000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2480000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120803000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
119871000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
165784000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
141536000 USD
CY2020Q4 us-gaap Assets
Assets
621636000 USD
CY2020Q1 us-gaap Assets
Assets
420206000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3751000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3408000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7188000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8940000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7646000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6814000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9165000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6846000 USD
us-gaap Operating Expenses
OperatingExpenses
39697000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
22000 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
144302000 USD
CY2020Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
140278000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
686000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1358000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27750000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26008000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
36103000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32549000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
208841000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
200193000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
314537000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
158023000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69363000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72359000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
28895000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10369000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
412795000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
621636000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
420206000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34172000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31655000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95973000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83479000 USD
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
13519000 USD
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
16852000 USD
us-gaap Cost Of Revenue
CostOfRevenue
33695000 USD
us-gaap Cost Of Revenue
CostOfRevenue
36886000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
20653000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
14803000 USD
us-gaap Gross Profit
GrossProfit
62278000 USD
us-gaap Gross Profit
GrossProfit
46593000 USD
CY2020Q4 us-gaap Selling Expense
SellingExpense
4753000 USD
CY2019Q4 us-gaap Selling Expense
SellingExpense
4067000 USD
us-gaap Selling Expense
SellingExpense
12614000 USD
us-gaap Selling Expense
SellingExpense
8549000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13173000 USD
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11605000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33887000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26806000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2705000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2110000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7715000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4044000 USD
CY2020Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
276000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
298000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
20631000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
18058000 USD
us-gaap Operating Expenses
OperatingExpenses
54216000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4848000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3255000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8062000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6896000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
1950000 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
1929000 USD
us-gaap Interest Expense
InterestExpense
5803000 USD
us-gaap Interest Expense
InterestExpense
3522000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3799000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
107000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
748000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5749000 USD
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1822000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10651000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2774000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5727000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5077000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2589000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4122000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1185000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-573000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1943000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
792000 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4542000 USD
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4504000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-646000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3330000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5125000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4367000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4922000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4142000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5125000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4367000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4922000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4418000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4542000 USD
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4504000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-646000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3330000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21142000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6615000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
39264000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5750000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16600000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2111000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38618000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9080000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-646000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3330000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12933000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7501000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6887000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5310000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4024000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
2002000 USD
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
-436000 USD
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
5134000 USD
mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-368000 USD
mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-577000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4583000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
256000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1285000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-758000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2224000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
485000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-304000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2691000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2410000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2517000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4396000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
523000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
227000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23553000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18156000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
184102000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
954000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
935000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-954000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185037000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
167070000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84995000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
-0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
23000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2341000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2019000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3692000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3848000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147275000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230883000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2477000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-509000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
172351000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
63493000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81380000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10185000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
253731000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73678000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
145935000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1654000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
704000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1268000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12860000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1217000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1047000 USD
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
818000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2008000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5262000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2679000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
991000 USD
CY2020Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
819000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3611000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21142000 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4542000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
412795000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
111311000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2709000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
624000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
868000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
121000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4662000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
119047000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
798000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84995000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
22735000 USD
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
697000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1182000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-986000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3172000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
341000 USD
CY2019Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
698000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3260000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6615000 USD
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4504000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
235260000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15261000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14746000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13143000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34172000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31655000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95973000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83479000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34172000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31655000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95973000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83479000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7217000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-4131000 USD
mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
4984000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8070000 USD
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
222819000 USD
CY2020Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
66735000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8151000 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6757000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
436000 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
329000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6370000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9768000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2992000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2624000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
11965000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14230000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
183110000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62307000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
120803000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
169123000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49252000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
119871000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3828 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10694 USD
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2565 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5895 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3891000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
15470000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
141536000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
17183000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
7065000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
165784000 USD
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2796000 USD
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4069000 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2746000 USD
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2485000 USD
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1478000 USD
CY2020Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2228000 USD
CY2020Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
168000 USD
CY2020Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
158000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7188000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8940000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4798000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3796000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1057000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1095000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
889000 USD
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
296000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
404000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
857000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
555000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
504000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1462000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
298000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9165000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6846000 USD
CY2020Q4 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
593000 USD
CY2019Q4 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
593000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1779000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
909000 USD
CY2020Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1357000 USD
CY2019Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1295000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4024000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2002000 USD
CY2020Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1950000 USD
CY2019Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1888000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
5803000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
2911000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
600000
CY2020Q2 mlab Sale Of Stock Underwriter Options Shares
SaleOfStockUnderwriterOptionsShares
90000
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
225.00
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3611000 USD
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3260000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6887000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5310000 USD
CY2020Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
320000 USD
CY2019Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-78000 USD
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-1127000 USD
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-986000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3931000 USD
CY2019Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3182000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5760000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4324000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
286000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
107.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
36000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
226.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
12000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
116.24
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
47000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
85.64
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
263000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
127.63
mlab Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Cumulative Effect Of Adjustment Vested In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsCumulativeEffectOfAdjustmentVestedInPeriod
1629000 USD
mlab Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Cumulative Effect Of Adjustment Vested In Period Net Of Tax
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsCumulativeEffectOfAdjustmentVestedInPeriodNetOfTax
1209000 USD
mlab Share Based Compensation Effect On Earning Per Share Basic
ShareBasedCompensationEffectOnEarningPerShareBasic
0.25
mlab Sharebased Payment Arrangement Expected Noncash Expense Increased Decrease Per Quarter
SharebasedPaymentArrangementExpectedNoncashExpenseIncreasedDecreasePerQuarter
194000 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4542000 USD
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4504000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-646000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3330000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5125000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4367000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4922000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4142000
CY2020Q4 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
CY2019Q4 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
251000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5125000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4367000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4922000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4418000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
926000
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
972000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
938000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
355000
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.750 pure
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.113 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.192 pure
CY2020Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
630000 USD
us-gaap Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit
-630000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34172000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
20653000 USD
CY2020Q4 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-26380000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5727000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31655000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
14803000 USD
CY2019Q4 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-19880000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5077000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95973000 USD
us-gaap Gross Profit
GrossProfit
62278000 USD
mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-64867000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2589000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83479000 USD
us-gaap Gross Profit
GrossProfit
46593000 USD
mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-42471000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4122000 USD
CY2020Q4 us-gaap Assets
Assets
621636000 USD
CY2020Q1 us-gaap Assets
Assets
420206000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
600000

Files In Submission

Name View Source Status
0001437749-21-001796-index-headers.html Edgar Link pending
0001437749-21-001796-index.html Edgar Link pending
0001437749-21-001796.txt Edgar Link pending
0001437749-21-001796-xbrl.zip Edgar Link pending
ex_215784.htm Edgar Link pending
ex_215785.htm Edgar Link pending
ex_215786.htm Edgar Link pending
ex_215787.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20201231.xsd Edgar Link pending
mlab-20201231_cal.xml Edgar Link unprocessable
mlab-20201231_def.xml Edgar Link unprocessable
mlab-20201231_lab.xml Edgar Link unprocessable
mlab-20201231_pre.xml Edgar Link unprocessable
mlab20201231_10q.htm Edgar Link pending
mlab20201231_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending